Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

ProPhase Labs (PRPH) Income towards Parent Company (2016 - 2025)

Historic Income towards Parent Company for ProPhase Labs (PRPH) over the last 16 years, with Q1 2025 value amounting to $8.7 million.

  • ProPhase Labs' Income towards Parent Company rose 128029.69% to $8.7 million in Q1 2025 from the same period last year, while for Sep 2025 it was $8.0 million, marking a year-over-year increase of 16981.23%. This contributed to the annual value of -$3.8 million for FY2024, which is 85497.51% down from last year.
  • As of Q1 2025, ProPhase Labs' Income towards Parent Company stood at $8.7 million, which was up 128029.69% from -$786000.0 recorded in Q4 2024.
  • ProPhase Labs' Income towards Parent Company's 5-year high stood at $12.5 million during Q1 2022, with a 5-year trough of -$8.3 million in Q4 2023.
  • Its 5-year average for Income towards Parent Company is $723294.1, with a median of -$741000.0 in 2024.
  • Over the last 5 years, ProPhase Labs' Income towards Parent Company had its largest YoY gain of 2395250.0% in 2021, and its largest YoY loss of 257080.75% in 2021.
  • Quarter analysis of 5 years shows ProPhase Labs' Income towards Parent Company stood at $9.6 million in 2021, then crashed by 125.4% to -$2.4 million in 2022, then plummeted by 241.61% to -$8.3 million in 2023, then surged by 90.59% to -$786000.0 in 2024, then soared by 1212.72% to $8.7 million in 2025.
  • Its Income towards Parent Company stands at $8.7 million for Q1 2025, versus -$786000.0 for Q4 2024 and -$1.6 million for Q3 2024.